Abstract Submission - International Symposium on ALS/MND

Abstract Submissions will reopen in Spring 2027

Abstracts for the 38th International Symposium on ALS/MND will re-open in Spring next year.

You can sign up for regular Symposium updates by contacting symposium@mndassociation.org or using the Sign up for updates page so that you don't miss any important dates and announcements. If you have any specific abstract-related queries, please use the contact form below.

Abstract Submission Information and FAQs

Themes

Authors will be asked to assign a theme to their abstract in the abstract submission portal. The themes last year are as follows but may be subject to change this year:

Epidemiology and Informatics (EPI)
Genetics and genomics (GEN)
In vitro experimental models (IVT)
In vivo experimental models (IVV)
Human cell biology and pathology (HCB)
Tissue biomarkers (BIO)
Pre-clinical therapeutic strategies (TST)
Clinical imaging and electrophysiology (IMG)
Clinical trials and trial design (CLT)
Disease stratification and phenotyping of patients (DSP)
Cognitive and psychological assessment and support (COG)
Clinical management and support (CMS)
Primary Lateral Sclerosis and upper motor neurone degeneration (PLS)

Can I submit an abstract on behalf of someone else?

No, abstracts must be submitted by the presenting author to ensure any corresponding emails go to them.

Do I need to register if my abstract is accepted?

Yes, presenting author's for both posters and oral talks will be required to pay the appropriate in-person registration fee. Formal acceptance of an abstract is conditional upon payment of the full registration fee. Refunds will be available in the event of an abstract being rejected.

If I submit an abstract for an oral presentation do I need to submit it again for a poster presentation?

No, due to the volume of abstracts we receive each year, we have a limited number of oral presentation slots. Therefore all abstracts submitted as an oral talk will be considered for both the oral presentations and poster presentations.

Where will my abstract be published?

Abstracts will be published in an online open access supplement of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. This abstract book will be published online on the Taylor and Francis website and will be found via the Symposium website (symposium.mndassociation.org). Abstracts accepted as ‘WIP/CP’ will be published on the MND Association’s Symposium website.

By submitting an abstract, you consent to give us the license to act on your behalf with the Taylor & Francis group to publish your abstract in the symposium supplement of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

What is WIP/CP?

WIP/CP stands for work in progress/care practice. WIP/CP is defined as: preliminary work (little or no data/results), care practice or case studies.

What happens after I submit an abstract?

Once the submission deadline has passed, abstracts will be reviewed by the Symposium Programme Committee. We will inform you of the decision in late August and if you have been accepted. This will be followed by a second notification in September which will include specific presentation theme/session, time and date information. Poster presenters will also receive details and instructions on poster guidelines and how to submit their poster material (poster PDF) to our virtual platform for our virtual delegates before the upload deadline.